BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2756678)

  • 1. [A mathematical model for predicting the efficacy of glucocorticoid therapy of glomerulonephritis].
    Bagdasarova IV; Ivanov DD
    Vrach Delo; 1989 Apr; (4):26-9. PubMed ID: 2756678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetically determined variability in cell glucocorticoid receptors as a factor in sensitivity to glucocorticoid therapy in the nephrotic syndrome].
    Liashko VN; Grinberg KN; Mukhin NA; Dziuba MT
    Vestn Akad Med Nauk SSSR; 1980; (6):28-32. PubMed ID: 7405376
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of morphological types of nephrotic glomerulonephritis and the number of glucocorticoid receptors of lymphocytes for prognosis of the effectiveness of glucocorticoid therapy].
    Sasu BI; Mukhin NA; Serov VV; Varshavskiĭ VA
    Arkh Patol; 1984; 46(6):21-6. PubMed ID: 6383286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the sensitivity to glucocorticoids in vitro].
    Mil'ko VI; Taradiĭ NN; Bagdasarova IV; Moskalenko NI; Ivanov DD
    Lab Delo; 1989; (2):27-8. PubMed ID: 2467052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucocorticoids in the treatment of patients with glomerulonephritis and the nephrotic syndrome].
    Kolesnyk MO; Lapchyns'ka II
    Lik Sprava; 1993 Sep; (9):23-8. PubMed ID: 8085341
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of the amount of somatic cell glucocorticoid receptors as one of the prospective approaches to the individual prognosis of glucocorticosteroid therapy].
    Mukhin NA; Liashko VN; Grinberg KN
    Ter Arkh; 1987; 59(5):69-73. PubMed ID: 3616948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The morphofunctional characteristics of the blood lymphocytes in steroid-sensitive and steroid-resistant glomerulonephritis].
    Bagdasarova IV; Ivanov DD; Afanas'eva VV
    Arkh Patol; 1991; 53(5):28-32. PubMed ID: 1883272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The immunodeficiency state and the efficacy of the glucocorticoid therapy of patients with glomerulonephritis and the nephrotic syndrome].
    Kolesnyk MO; Dorets'kyĭ VV
    Lik Sprava; 1992; (11-12):53-5. PubMed ID: 1292222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic drug therapy in steroid-resistant glomerulonephritis.
    White RH
    Proc R Soc Med; 1967 Nov; 60(11 Part 1):1164-8. PubMed ID: 6060717
    [No Abstract]   [Full Text] [Related]  

  • 10. [The efficacy of the glucocorticoid and cytostatic therapy of lupus glomerulonephritis].
    Diadyk AI; Vasilenko IV; Siniachenko OV; Iarovaia NF; Shpilevaia NI; Bagriĭ AE; Khomenko MV; Chernykh OS; Efremenko VA; Zviagina TV
    Ter Arkh; 1992; 64(10):111-4. PubMed ID: 1485238
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary RBP and glucocorticoid hormone therapy sensibility in adult primary nephrotic syndrome].
    Chen X; Cheng MC; Duan SB; Xia YC
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):175-7. PubMed ID: 12536664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptors and steroid sensitivity in normal and neoplastic human lymphoid tissues: a review.
    Homo-Delarche F
    Cancer Res; 1984 Feb; 44(2):431-7. PubMed ID: 6362849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids in renal disease. Theoretical basis, consequences and efficacy of use in the pediatric patient.
    Friedman AL; Chesney RW
    Am J Nephrol; 1982; 2(6):330-41. PubMed ID: 6762095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amino acid metabolism in steroid therapy of nephropathies].
    Pyrig LA; Nikula TD
    Vrach Delo; 1969 Feb; 2():135-7. PubMed ID: 5779366
    [No Abstract]   [Full Text] [Related]  

  • 15. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-laboratory pattern and effectiveness of glucocorticoid therapy of patients with primary diffuse mesangioproliferative glomerulonephritis].
    Diadyk AI; Dikshteĭn EA; Vasilenko IV; Siniachenko OV; Kobets VG
    Ter Arkh; 1987; 59(8):35-7. PubMed ID: 3686443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-inflammatory activity of glucocorticoids in nephrology].
    Nykula TD; Bondur VV; Moĭseienko VO; Aleksieieva NH
    Lik Sprava; 2013; (5):94-8. PubMed ID: 24605641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucocorticoid receptors and predicting the efficacy of glucocorticoid therapy of nephritis].
    Sasu BI; Mukhin NA; Liashko VN; Freĭdin MI
    Klin Med (Mosk); 1984 Apr; 62(4):75-9. PubMed ID: 6737971
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and pathologic correlations in infantile nephrotic syndrome].
    Gaboardi F; Chiccoli C
    Minerva Pediatr; 1971 Mar; 23(13):569-75. PubMed ID: 5576857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.